Advantage PAN Malaria Card Rapid Diagnostic Test Kit
Pack Sizes Available
Product Description
Technical Specifications
- Test Principle: Sandwich immunochromatographic assay (lateral flow)
- Detection Target: Pan-specific plasmodium lactate dehydrogenase (pLDH) antigen from all four Plasmodium species
- Species Detected: P. falciparum, P. vivax, P. malariae, P. ovale
- Specimen Type: Human whole blood (fingerstick capillary blood or venous blood with anticoagulant)
- Test Format: Rapid diagnostic test (RDT) card with see-through device design
- Pack Sizes: 25 tests/kit, 50 tests/kit, 100 tests/kit; individually pouched
- Result Time: 20 minutes
- Analytical Sensitivity: >100 parasites per µL of blood for P. falciparum (pLDH) and P. vivax (pLDH)
- Clinical Sensitivity: Excellent (per WHO Malaria RDT Evaluation Round 5, 2013)
- Specificity: >99% (no cross-reactivity with dengue, leptospirosis, HIV, HBV, HCV, tuberculosis, syphilis, other febrile illnesses)
- Storage Conditions: 4-30°C (ambient temperature stable, no refrigeration required)
- Shelf Life: 24-30 months from date of manufacture
- WHO Evaluation: Evaluated by WHO using wild and cultured malaria-positive sample panels
- Kit Contents: Test devices (individually sealed), assay buffer, blood collection pipettes, instructions for use
- Regulatory Status: CE marked, meets ISO requirements for in-vitro diagnostic devices
Frequently asked questions
The Advantage PAN Malaria Card is a rapid visual immunoassay for qualitative detection of all four human Plasmodium species (P. falciparum, P. vivax, P. malariae, and P. ovale) that cause malaria. It detects pan-specific plasmodium lactate dehydrogenase (pLDH) antigen present in infected red blood cells. The test provides results within 20 minutes using whole blood from a fingerstick or venous sample, making it suitable for point-of-care diagnosis without laboratory equipment.
The test can detect parasitemia levels above 100 parasites per microliter of blood for both P. falciparum (pLDH) and P. vivax (pLDH). This sensitivity level is clinically relevant for symptomatic malaria infections that require treatment. The test has been evaluated by WHO using panels of wild and cultured malaria-positive samples and demonstrates excellent sensitivity and specificity according to WHO Malaria RDT evaluation standards.
PAN malaria tests like the Advantage PAN Malaria Card detect all four Plasmodium species (P. falciparum, P. vivax, P. malariae, P. ovale) through pan-specific pLDH antibodies. P.f-specific tests detect only P. falciparum using HRP-2 (histidine-rich protein-2) antibodies. PAN tests are useful in regions where multiple species circulate or where non-falciparum malaria (particularly P. vivax) is prevalent. Some combination tests (like PAN+Pf) detect both pan-pLDH and Pf-HRP-2 to differentiate falciparum from other species.
The Advantage PAN Malaria Card has a shelf life of 24 to 30 months when stored at temperatures between 4°C and 30°C. This extended temperature stability is critical for tropical and subtropical regions where cold chain infrastructure may be unreliable. The test can be stored at ambient temperatures without refrigeration, making it practical for stockpiling in resource-limited settings and field deployment during outbreak response.
No, the test has been evaluated for cross-reactivity with common febrile illnesses found in malaria-endemic regions. Testing included samples positive for dengue, rheumatoid factor, leptospirosis, HIV, hepatitis B and C, tuberculosis, syphilis, brucellosis, and scrub typhus. The test demonstrated high specificity (>99%) with no significant cross-reactivity, meaning it accurately distinguishes malaria infection from other causes of fever.
While the test provides rapid, reliable diagnosis suitable for most clinical settings, microscopy remains the gold standard for malaria diagnosis and is recommended for confirmation when available. Rapid diagnostic tests like Advantage PAN are ideal for point-of-care settings where microscopy is unavailable or impractical (rural clinics, nighttime presentations, field operations), for screening large populations, and for guiding immediate treatment decisions. Microscopy is still valuable for quantifying parasitemia, identifying species definitively, and monitoring treatment response.
Microlisa HIV Ag & Ab 4th Generation ELISA Test Kit
Blood screening exists in a category of laboratory work where the margin for error is not just professionally unacceptable but medically catastrophic. A false negative in HIV screening does not just fail a test. It compromises patient safety, undermines transfusion protocols, and exposes healthcare systems to risks that nobody wants to calculate. Microlisa HIV Ag & Ab 4th Generation ELISA was engineered to close the detection window that makes early HIV infection so difficult to identify reliably. This is an in-vitro qualitative enzyme immunoassay designed for simultaneous detection of antibodies to HIV-1 (including Group O and subtype C prevalent in India), HIV-2, and HIV-1 p24 antigen in human serum or plasma. The test is intended for screening of blood donors, diagnostic testing of individuals at risk for HIV infection, and clinical evaluation of patients with AIDS-related symptoms. It represents the fourth generation of HIV ELISA technology, which detects both antibodies and antigens simultaneously rather than antibodies alone. The clinical advantage of 4th generation testing is the shortened window period. Traditional antibody-only tests miss early seroconversion cases where HIV-1 p24 antigen is present but antibodies have not yet developed to detectable levels. By detecting p24 antigen during the acute infection phase (typically 2 to 4 weeks post-exposure), this assay identifies infections approximately 1 to 2 weeks earlier than 3rd generation antibody-only tests. That earlier detection matters critically in blood donor screening and post-exposure monitoring. The assay is based on sandwich ELISA methodology. Microtiter wells are pre-coated with HIV envelope proteins (gp41, C-terminus of gp120 for HIV-1, and gp36 for HIV-2) and anti-p24 monoclonal antibodies. When specimens are added, any HIV antibodies or p24 antigen present bind to the coated antigens or antibodies. After washing, horseradish peroxidase (HRPO) conjugated antigens and anti-p24 antibodies are added, forming a sandwich complex. The colorimetric reaction develops proportionally to the amount of HIV antibodies or antigen present, read at 450nm absorbance. The kit uses color-coded reagents to monitor procedural steps, reducing protocol errors during multi-step workflows. Breakaway microwell strips allow testing flexibility from single specimens to full 96-well plate runs. Storage stability is maintained at 2-8°C with a shelf life of 24 months unopened. Total assay time including incubation steps is approximately 120 minutes. Sensitivity and specificity meet international standards for 4th generation HIV screening. Clinical evaluations demonstrate 100% sensitivity in detecting seroconversion panels and p24 antigen standards quantified down to 200 pg/ml. Specificity exceeds 99.5% when tested against large sample populations. The test detects all major HIV-1 subtypes including Group O and subtype C, which are epidemiologically significant in the Indian subcontinent. For distributors supplying blood banks, transfusion centers, diagnostic laboratories, and public health screening programs, Microlisa HIV Ag & Ab represents a clinically validated 4th generation screening platform with predictable reorder cycles. Sara Wellness has been exporting in-vitro diagnostic kits and laboratory reagents from India for 15 years.
Human Serum Coombs Antisera (Antihuman Globulin Reagent)
Blood banking operates on a fundamental requirement that most people never think about until something goes wrong. Every unit of blood transfused must be confirmed compatible with the recipient's immune system. Every pregnant woman screened for antibodies that could harm her unborn child. Every suspected case of hemolytic anemia investigated for antibodies attacking the patient's own red blood cells. None of this happens without Coombs antisera making the invisible antibodies visible. Human Serum Coombs Antisera is the reagent that makes antiglobulin testing possible in blood banks and immunohematology laboratories worldwide. This is antihuman globulin (AHG) reagent used in both direct and indirect antiglobulin tests (Coombs tests) to detect antibodies and complement components bound to red blood cell surfaces or present free in serum. The reagent is produced by immunizing animals (typically rabbits) with human immunoglobulins, which induces production of polyclonal antibodies specific for human IgG antibodies and complement factor C3d. When added to washed red blood cells coated with IgG or complement, the antihuman antibodies bind to the human antibodies and form bridges between adjacent sensitized cells, causing visible agglutination. The direct antiglobulin test (DAT) detects antibodies or complement already bound to red blood cell surfaces in vivo. This test is critical for diagnosing autoimmune hemolytic anemia, investigating hemolytic transfusion reactions, and diagnosing hemolytic disease of the fetus and newborn. The indirect antiglobulin test (IAT) detects free antibodies circulating in serum or plasma. This test is essential for pre-transfusion antibody screening, crossmatching blood units for compatibility, and prenatal antibody screening in pregnant women. Polyspecific Coombs antisera (like the green-colored reagent shown) contains antibodies against both IgG and C3d complement, providing broad-spectrum detection. When the polyspecific reagent produces a positive result, monospecific antisera (anti-IgG alone or anti-C3d alone) are used for follow-up testing to characterize whether red cells are coated with IgG antibodies, complement, or both. This differentiation is clinically important because it helps determine the cause and clinical significance of the positive test. The reagent is typically dyed green using patent blue and tartrazine to allow easy visual identification during laboratory workflows where multiple reagents are used simultaneously. Storage at 2-8°C maintains reagent potency until the expiration date printed on the bottle, typically 18 to 24 months from manufacture. The reagent contains sodium azide (0.1% w/v) as a preservative, which inhibits bacterial growth but requires careful handling and disposal. Each dropper bottle delivers approximately 40 microliters per drop, allowing precise volumetric dosing during testing. The reagent must not be diluted and should not be used if turbid, as turbidity indicates bacterial contamination or protein aggregation that will compromise test performance. For distributors supplying blood banks, hospital transfusion services, reference immunohematology laboratories, and donor screening centers, Coombs antisera represents an essential reagent with consumption directly tied to transfusion volume and prenatal screening programs. Sara Wellness has been exporting immunohematology reagents and blood banking supplies from India for 15 years.
Acon Urine HCG Pregnancy Test Kit
Two lines or one. That's all a pregnancy test comes down to. But ask any pharmacist, clinic manager, or hospital procurement officer how much rides on those two little lines being reliably accurate — and the conversation gets more serious very quickly. Because a false result, in either direction, is not just a product failure. It's a human failure. The ACON urine hCG Pregnancy Test Kit is built on the understanding that reliability is non-negotiable. ACON Laboratories, headquartered in San Diego and one of the world's leading manufacturers of rapid diagnostic tests, uses a chromatographic immunoassay format that detects human chorionic gonadotropin — the pregnancy hormone — in urine at a sensitivity threshold of 25 mIU/mL. That's the level at which hCG is consistently detectable in clinically confirmed early pregnancies. The test is calibrated against the WHO International Standard (3rd edition) and has FDA clearance, two regulatory benchmarks that procurement managers across almost every market in the world recognise and accept as evidence of validated performance. The test works in three minutes. First morning urine is preferred for maximum accuracy, but the test can be performed at any point during the day. Each strip is individually foil-sealed, maintaining integrity until the moment of use. The result reads simply: two lines positive, one line negative, no line in the control window means the test is invalid and should be repeated. Nothing about the procedure requires training or lab equipment — which is precisely why this product moves so effectively across pharmacy chains, government health outreach programmes, antenatal clinics, and over-the-counter retail. For importers and distributors sourcing diagnostic rapid tests in volume, the ACON hCG strip kit offers the rare combination of brand recognition, regulatory compliance, and competitive unit economics. The 50-strip box format is the standard across institutional procurement — hospitals, clinics, and NGO supply chains all order in this configuration. Shelf life runs to 36 months from manufacture under standard storage between 2 and 30°C, which makes inventory planning straightforward even for markets with longer supply chains. Sara Wellness has been exporting diagnostic and lab supply products to buyers across Africa, the Middle East, and Southeast Asia for 15 years. Rapid test kits like the ACON hCG strip are among the highest-velocity SKUs in our catalogue. We understand volume pricing, documentation requirements for IVD products in different export markets, and the importance of consistent batch quality across repeated shipments. Reach out with your volume requirement and we will put together a quote worth looking at.